While previous studies have revealed that oncogenic GNAS mutants promote hyperplastic growth and tumorigenesis67–69, our study demonstrates that they also promote immune evasion by repressing CXCL9/10/11 across human cancers. This evidence concerns the gene CXCL9 and cancer.